Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

"Variations in the use of secondary CVD prevention medications over time in our contemporary cohort study suggest little to no improvement globally." HealthDay News — Use of secondary cardiovascular ...

Please provide your email address to receive an email when new articles are posted on . Many people requiring secondary prevention drugs for CVD do not receive them. This trend persisted even in ...

Please provide your email address to receive an email when new articles are posted on . A polypill-based strategy may be cost-effective for primary CVD prevention in historically underserved ...

Broader uptake of single-pill combination (SPC) therapies—polypills—to simplify primary or secondary prevention of cardiovascular disease could have a huge impact on a global scale in the coming ...

Boston, MA - A new study demonstrates that providing a multidrug regimen of aspirin, two blood-pressure drugs, and a statin in the developing world is affordable and could have the profound effect of ...

Diet, exercise may lower plaque build-up in coronary arteries The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease. The USPSTF concluded ...

The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly as cardiovascular prevention drugs, Esperion announced Friday.

Cohort studies like Framingham and Bogalusa have been pivotal in identifying cardiovascular risk factors and understanding early-life exposures' long-term impact. The meeting included new evidence and ...

CRP Not Likely to Be Causal Factor for CVD, New Meta-Analysis Finds British researchers conclude that CRP is unlikely to be a causal factor for cardiovascular disease. Another expert says it does help ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Features of the 2024 Scientific Sessions program include diverse content ...

The incidence of cardiovascular disease has decreased in the United Kingdom over the past two decades, but the overall burden has remained high, according to new registry data. Specifically, rates of ...